NUP153-AS1
gene geneOn this page
Summary
NUP153-AS1 (NUP153 antisense RNA 1, HGNC:55217) is a long non-coding RNA gene on chromosome 6p22.3.
At a glance
- Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:55217 |
| Approved symbol | NUP153-AS1 |
| Name | NUP153 antisense RNA 1 |
| Location | 6p22.3 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Ensembl gene | ENSG00000272269 |
| Ensembl biotype | lncRNA |
| Entrez | 105374952 |
| RNAcentral | URS0000A777EE — lncRNA, 1237 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 11 — 11 lncRNA
ENST00000606771, ENST00000769169, ENST00000769170, ENST00000769171, ENST00000769172, ENST00000769173, ENST00000769174, ENST00000769175, ENST00000769176, ENST00000769177, ENST00000769178
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000606771 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00004130063 | 17710789 | 17711153 |
| ENSE00004130075 | 17706094 | 17707626 |
Expression profiles
Bgee: expression breadth ubiquitous, 155 present calls, max score 70.36.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 4.6393 / max 124.1387, expressed in 1439 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 66160 | 3.9113 | 1349 |
| 66159 | 0.4586 | 205 |
| 66158 | 0.2224 | 75 |
| 66161 | 0.0470 | 7 |
Top tissues by expression
241 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| granulocyte | CL:0000094 | 70.36 | gold quality |
| sural nerve | UBERON:0015488 | 68.53 | gold quality |
| cartilage tissue | UBERON:0002418 | 68.09 | gold quality |
| stromal cell of endometrium | CL:0002255 | 66.79 | gold quality |
| gastrocnemius | UBERON:0001388 | 65.73 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 65.18 | gold quality |
| muscle of leg | UBERON:0001383 | 64.98 | gold quality |
| spleen | UBERON:0002106 | 63.53 | gold quality |
| omental fat pad | UBERON:0010414 | 63.23 | gold quality |
| peritoneum | UBERON:0002358 | 63.17 | gold quality |
| right lobe of liver | UBERON:0001114 | 63.08 | gold quality |
| adipose tissue of abdominal region | UBERON:0007808 | 62.00 | gold quality |
| vermiform appendix | UBERON:0001154 | 61.66 | gold quality |
| ventricular zone | UBERON:0003053 | 61.58 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 60.89 | gold quality |
| lymph node | UBERON:0000029 | 60.37 | gold quality |
| colonic epithelium | UBERON:0000397 | 59.74 | silver quality |
| apex of heart | UBERON:0002098 | 59.03 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 58.97 | gold quality |
| left adrenal gland | UBERON:0001234 | 58.76 | gold quality |
| leukocyte | CL:0000738 | 58.58 | gold quality |
| right coronary artery | UBERON:0001625 | 58.49 | gold quality |
| ganglionic eminence | UBERON:0004023 | 58.23 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 58.19 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 58.06 | gold quality |
| monocyte | CL:0000576 | 57.79 | gold quality |
| esophagus mucosa | UBERON:0002469 | 57.61 | gold quality |
| subcutaneous adipose tissue | UBERON:0002190 | 57.39 | gold quality |
| left coronary artery | UBERON:0001626 | 57.22 | gold quality |
| adrenal gland | UBERON:0002369 | 57.12 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.28 |
Regulation
Is transcription factor: no
Cross-species orthologs
0 orthologs
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.